A role for APOE4 in driving Aβ and p‐tau deposition is well established,17 and it has been suggested that APOE4 is also associated with increased severity and spread of Lewy bodies, independently of AD pathology.21, 22, 23. This evidence concerns the gene MAPT and Alzheimer disease.